Denali Therapeutics Inc (DNLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 52,480 | 42,141 | 12,514 | 5,285 | 22,939 |
| Gross Profit | 52,480 | 42,141 | 12,514 | 5,285 | 22,939 |
| Operating Expenses | 113,896 | 108,639 | 89,635 | 90,878 | 84,756 |
| Operating Income | -61,416 | -66,498 | -77,121 | -85,593 | -61,817 |
| Other Income | 2,649 | 1,278 | 1,285 | 1,005 | 1,126 |
| Pre-tax Income | -58,767 | -65,220 | -75,836 | -84,588 | -60,691 |
| Income Tax | 27 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -58,794 | -65,220 | -75,261 | -84,588 | -60,691 |
| Net Income | $-58,794 | $-65,220 | $-75,261 | $-84,588 | $-60,691 |
| EPS Basic Total Ops | -0.48 | -0.53 | -0.62 | -0.69 | -0.50 |
| EPS Basic Continuous Ops | -0.48 | -0.53 | -0.62 | -0.69 | -0.50 |
| EPS Diluted Total Ops | -0.48 | -0.53 | -0.62 | -0.69 | -0.50 |
| EPS Diluted Continuous Ops | -0.48 | -0.53 | -0.62 | -0.69 | -0.50 |
| EBITDA(a) | $-58,853 | $-62,792 | $-72,595 | $-80,746 | $-57,118 |